View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Consulting, Auditing, and Assessments

NSF's unique team of ex-regulatory agency inspectors and highly experienced industry professionals provide authoritative consulting and auditing services to major pharmaceutical and biopharmaceutical companies and regulatory agencies worldwide.

Consulting and auditing services

NSF’s unique team of ex-regulatory agency inspectors and highly experienced industry professionals provide authoritative consulting and auditing services to major pharmaceutical and biopharmaceutical companies and regulatory agencies worldwide.

The company provides in-depth, expert assessment of technical issues and help outsource your entire supplier audit programme, as well as specialist services in areas such as cost-effective quality management, manufacturing of major dosage forms including sterile and biotech products, pharmaceutical packaging, clinical trial manufacturing, supply and good clinical practice (GCP), and pharmacovigilance (PV), as well as sterilisation procedures, pharmaceutical microbiology, supply chain assurance, good distribution practice (GDP), process and analytical method validation, regulatory compliance for computers and automated control systems, and pharmaceutical water systems.

NSF can help with:

  • Preparing for regulatory inspections
  • Due diligence audits for acquisitions
  • QS audits
  • Mock regulatory inspections
  • Good manufacturing practice (GMP) compliance audits
  • Good laboratory practice (GLP), GCP, PV, clinical laboratory improvement amendments (CLIA) and Biotechnology monitoring programme (BIMO) audits
  • Over-the-counter (OTC) current good manufactruring practices (cGMP) audits

Data integrity audits and assessments offerings include:

  • Data integrity focused audits conducted by NSF’s pharmaceutical and biotechnology experts, providing findings and recommendations for closing gaps
  • Third-party data integrity audits such as contract manufacturing organisations (CMO), Commonwealth telecommunications organisation (CTO), contract research organisations (CRO), and other service providers or prospective suppliers
  • Mock inspections with data integrity focus conducted by NSF’s team of former US Food and Drug Administration (FDA) and Medicines and Healthcare Products Regulatory Agency (MHRA) regulators help your company prepare for the real inspection
  • Data integrity assessments; a collaborative approach to identify system weaknesses and find solutions by utilising its team’s expertise.
  • Auditor training by NSF’s pharma biotech experts

Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology